Overview

Effects of Low Dose Naltrexone in Fibromyalgia

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

Low Dose Naltrexone (LDN) has been reported anecdotally to reduce the symptoms of Fibromyalgia, a Chronic Multisystem Illness. The drug may work by regulating natural pain-reducing systems. In this study, we will administer both LDN and placebo to a small group of individuals with Fibromyalgia and Gulf War Syndrome, both Chronic Multisymptom Illnesses, to assess the drug's efficacy in treating the condition.

Phase:

N/A

Details

Lead Sponsor:

Stanford University

Collaborator:

American Fibromyalgia Syndrome Association

Treatments:

Naltrexone